Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02576301
Title Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS
Acronym AML
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OXiGENE
Age Groups: adult
Covered Countries USA

No variant requirements are available.